Cipla Therapeutics and SIGA Technologies enter into strategic partnership
Cipla Therapeutics, an affiliate of Cipla and SIGA Technologies announced entering into a strategic partnership to deliver…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
BARDA
Moderna commences trial of COVID-19 vaccine in children
The study will assess the safety and effectiveness of two doses of mRNA-1273 given 28 days apart in children aged six months to…
US FDA Advisory Committee supports EUA for Moderna’s COVID-19 vaccine
The primary analysis conducted on 196 cases indicated a vaccine efficacy rate of 94.1 per cent
Moderna announces dosing of first adolescent participants in Phase II-III trials of COVID-19 vaccine
Phase II-III trials are expected to enrol 3,000 healthy participants
Moderna to supply six million doses of COVID-19 vaccine to Israel
The company has already initiated the rolling regulatory review process with the Ministry of Health in Israel
UK to procure additional two million doses of mRNA vaccine against COVID-19
UK government has now secured seven million doses of mRNA-1273
EMA begins rolling review of Moderna’s COVID-19 vaccine candidate
Moderna also announced a supply agreement with the UK government to supply mRNA-1273, if approved for use by MHRA
J&J signs pact with US for 100 million doses of COVID-19 vaccine
The US government is committing over $1 billion for this agreement
Actemra/RoActemra, arthritis drug from Roche fails to meet primary endpoint of COVID-19 trial
The COVACTA study did not meet its primary endpoint of improved clinical status in hospitalised adult patients with severe…
Moderna gets further $472 million US award for coronavirus vaccine development
The US-based drug maker said the additional funding will support its late-stage clinical development including the expanded Phase…